Orgenesis Inc.
ORGS · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $210,299 | $252,595 | $192,425 | $15,833 |
| - Cash | $204 | $77 | $565 | $837 |
| + Debt | $17,297 | $13,021 | $27,831 | $22,621 |
| Enterprise Value | $227,392 | $265,539 | $219,691 | $37,617 |
| Revenue | $347 | $246 | $141 | -$13,599 |
| % Growth | 41.1% | 74.5% | 101% | – |
| Gross Profit | -$238 | -$749 | -$617 | -$16,768 |
| % Margin | -68.6% | -304.5% | -437.6% | 123.3% |
| EBITDA | -$7,663 | -$8,016 | -$8,806 | -$43,752 |
| % Margin | -2,208.4% | -3,258.5% | -6,245.4% | 321.7% |
| Net Income | $9,120 | -$8,904 | -$9,765 | -$34,392 |
| % Margin | 2,628.2% | -3,619.5% | -6,925.5% | 252.9% |
| EPS Diluted | -0.19 | -0.23 | -0.29 | -2.09 |
| % Growth | 17.4% | 20.7% | 86.1% | – |
| Operating Cash Flow | -$4,630 | -$5,907 | -$4,441 | -$502 |
| Capital Expenditures | -$58 | -$1 | -$204 | -$55 |
| Free Cash Flow | -$4,688 | -$5,908 | -$4,645 | -$557 |